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Syncope is a common problem in adolescents and most
patients can be managed conservatively with lifestyle
modiﬁcations.1 Some patients may beneﬁt from medications
to either augment blood pressure or alleviate tachycardia;
these strategies alone, however, often do not result in
complete resolution of symptoms.2,3 For those most severely
affected, syncope can be severely debilitating, with inability
to attend full-time education and partake in normal activities.
These patients have often tried multiple pharmacotherapeutic
strategies and have often been reviewed by many different
subspecialists. Patients on the most severe end of the
spectrum often have an underlying dysautonomia; conditions
such as hypermobility, postural orthostatic tachycardia
syndrome (POTS), and chronic fatigue are frequently
described to coexist.4
The Closed Loop Stimulation (CLS) function has been
successfully used in patients with vasovagal syncope.5,6 The
CLS algorithm works by monitoring right ventricular
impedance, which is thought to be one of the ﬁrst physio-
logical changes prior to syncope. Early detection and
chronotropic augmentation of cardiac output is thought to
be the mechanism behind the increased beneﬁt when
compared with heart rate–based algorithms. We describe
the use of the CLS algorithm in a pediatric patient with
dysautonomia, POTS, and severe orthostatic intolerance.
Placement of the pacemaker resulted in a dramatic improve-
ment in symptoms and allowed a patient who was conﬁned
to the hospital to embark on a path to recovery.
Case report
An 11-year-old girl was referred with a history of syncopal
episodes. She did not have any preceding medical problems.
There was a distant family member who had been diagnosed
with long QT syndrome. The episodes occurred both at restKEYWORDS Dysautonomia; POTS; Pacemaker; Closed loop; Pediatric
(Heart Rhythm Case Reports 2016;0:1–3)
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prodrome. She did not have any features suggestive of
hypermobility syndrome or connective tissue disease. There
was a 6- to 12-month history of fatigue, which became
progressively worse over the following year. A baseline
electrocardiogram and echocardiogram were both normal.
Over the following 12 months, the syncopal episodes
became more frequent. A head-up tilt test was performed;
the heart rate reached a maximum of 148 beats per minute,
17 minutes into the test (baseline 85 beats per minute) and
the blood pressure dropped to 69/53 mm Hg, at which point
the patient became syncopal. The patient continued to have a
borderline tachycardia during the syncopal event. A couple
of months later she had a syncopal episode at school. During
one of her lessons she became dizzy, with associated blurry
vision. She collapsed onto the ﬂoor and was unresponsive.
The school nurse assessed her immediately and she was said
to be pulseless. Chest compressions were given for 30
seconds and she became rousable. Owing to parental
concern, an adrenaline challenge was performed, which
demonstrated appropriate shortening of the QT interval; a
loop recorder was also implanted at the same time. Initial
medical treatments consisted of midodrine and ﬂudrocorti-
sone. A beta-blocker was tried initially; however, it was
discontinued owing to severe fatigue after administration.
Psychological support was provided for the patient by a
multidisciplinary team. The loop recorder documented multi-
ple episodes of collapse; some of these were preceded by
tachycardia and some were associated with a normal
heart rate.
The episodes of collapse were sometimes associated with
tonic posturing of the trunk and seizure-like episodes.
Neurologic investigations to rule out a neurologic cause for
her recurrent of collapses included brain magnetic resonance
imaging and electroencephalogram: these were both normal.
A collapse in hospital during electroencephalogram mon-
itoring demonstrated a 7-second episode of complete heart
block (Figure 1); this was also evident on the loop recorder.
We elected to place a single-chamber ventricular pacemaker
because of the previous episode of collapse and requirement
for cardiopulmonary resuscitation. The pacemaker was set topen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2016.07.009
Figure 2 Chest radiograph shows Biotronik Closed Loop Stimulation
system, implanted in the axilla.
KEY TEACHING POINTS
 Recurrent syncope is a common problem in young
patients. Most cases are treatable with a
combination of medications, lifestyle
modiﬁcations, and psychological support.
 Dysautonomia is an uncommon cause of syncope in
this age group; however, when it is present,
individuals can be profoundly affected with life-
altering symptom. Medical treatment of this group
of patients is often unsuccessful.
 We report on a patient refractory to medical
treatment, who had a dramatic improvement in
symptoms after implantation of the Biotronik
Closed Loop System.
Heart Rhythm Case Reports, Vol 0, No 0, Month 20162VVI at 50 beats per minute; at follow-up it was found to be
pacing 5%–10% of the time. We recognized that the pace-
maker was unlikely to improve the majority of the syncopal
episodes, as most were not related to bradycardia. The
patient had extensive psychology input and we felt that a
secondary conversion disorder was unlikely. Autoantibodies
for ganglionic AChR receptor were negative on 2 separate
occasions. The patient’s condition deteriorated, requiring
multiple extended hospital admissions. Ivabradine 2.5 mg 3
times daily was commenced and despite some initial
improvement, the collapses continued. Octreotide (intra-
muscular) was administered at a high dose; however, this
also did not improve symptoms. Collapses were occurring
10–20 times per day, and the patient was unable to mobilize
from her bed. We decided to upgrade the pacemaker to a
CLS system. This procedure was performed when the patient
was 14 years old (weight 55 kg, height 160 cm). A Select
Secure 69-cm atrial lead was placed and the existing pace-
maker was upgraded to an Epyra DR-T (Biotronik GmbH
& Co) (Figure 2). The pacemaker was programmed with a
rate of 60–140, with an AV delay of 180 msec, with a
medium sensor threshold (CLS feature). The pacemaker
demonstrated 44% atrial pacing and no ventricular pacing.Figure 1 This electroencephalogram (EEG) tracing demonstrates an
episode of complete heart block (arrows) presumably related to dysautono-
mia. There was no seizure activity documented on the EEG when the patient
was symptomatic.There was an immediate improvement in the patient’s color
the following morning and she was able to mobilize better.
She was discharged from hospital 4 days after implantation;
she had been an inpatient for 6 weeks by this stage. She has
had occasional episodes of syncope since discharge; how-
ever, her quality of life has greatly improved. She has
managed to return to school and has resumed some of her
normal activities.Discussion
This report demonstrates the usefulness of the CLS pace-
maker for a pediatric patient with severe orthostatic intoler-
ance secondary to dysautonomia. Patients with this severity
of symptoms are uncommon; they are, however, often
refractory to pharmacologic treatment and can require
extended hospital admission. The CLS system managed to
improve this patient’s symptoms when other treatment
modalities were unsuccessful.
Orthostatic intolerance in the pediatric age group is often
multifactorial. There are often overlapping phenotypes of
neurocardiogenic syncope, POTS, and dysautonomia. Psy-
chosomatic symptoms also are common and can either be the
main cause of syncope at presentation or develop over time if
appropriate psychological support is not readily available.1
Our patient demonstrated features of POTS on the tilt test,
yet some of the collapses documented on loop recorder
tracings showed a normal heart rate. Autoimmune dysauto-
nomia is most likely the underlying cause of this patient’s
condition. The ganglionic AChR antibody test was negative;
however, only 50% of patients who have autoimmune
ganglionopathy have a positive result.7 Given the fact that
other neurologic symptoms have not developed over time,
and that there was an improvement in symptoms with the
CLS pacemaker, another underlying neurologic diagnosis is
unlikely.
The CLS system works by sensing changes in right
ventricular impedance.8,9 For patients with orthostatic
3Shortland et al Closed Loop System for Dysautonomiaintolerance, postural change causes decreased venous return
to the heart, which in turn increases myocardial contractility.
The CLS algorithm detects this increase in contractility and
augments the heart rate, thus increasing cardiac output.
Algorithms using heart rate drop, may be providing chrono-
tropy too late to prevent syncope. This may account for the
better results for some types of orthostatic intolerance using
the CLS system.6
The most interesting thing about this report is the fact that
a pacemaker that works by accelerating the heart rate seemed
to dramatically improve symptoms in a patient whose
collapses were predominantly sinus rhythm / sinus tachy-
cardia. It is possible that in patients with dysautonomia, the
CLS algorithm somehow supports a dysfunctional auto-
nomic nervous system by increasing and decreasing the heart
rate in response to orthostatic conditions. The fact that the
patient is using the pacemaker 44% of the time, despite a
moderate sensor setting and a relatively sedentary lifestyle
still, may support this theory. Patients with this severity of
symptoms are, thankfully, quite rare; however, for those that
are refractory to medical therapy, this type of pacemaker is
worth considering.References
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